Developing greener synthesis processes is an inescapable necessity to transform the
industrial landscape, mainly in the pharmaceutical sector, into a long-term, sustainable …

Pulmonary fibrosis (PF) is a progressive, and life-threatening interstitial lung disease which
causes scarring in the lung parenchyma and thereby affects architecture and functioning of …

Small molecule therapeutics represent the majority of the FDA-approved drugs. Yet, many
attractive targets are poorly tractable by small molecules, generating a need for new …

This study aims to obtain a valuable mixture of short-chain peptides from hempseed as a
new ingredient for developing nutraceutical and functional foods useful for preventing …

Oligonucleotides (ONs) are acquiring clinical relevance and their demand is expected to
grow. However, the ON production capacity is currently limited by high manufacturing costs …

Fibrosis, a disease characterized by an excess accumulation of extracellular matrix
components, could lead to organ failure and death, and is to blame for up to 45% of all …

Piper gaudichaudianum Kunth essential oil (EO) is a natural source of bioactive
components, having multiple therapeutic applications. Its chemical composition is highly …

In peptide synthesis, the issues related to poor sustainability, long reaction times and high
process mass intensity (PMI) are necessary to promote actions aimed at redefining …

Therapeutic oligonucleotides (ONs) have great potential to treat many diseases due to their
ability to regulate gene expression. However, the inefficiency of standard purification …

Purifications of biologics can be improved using 3D printed stationary phases with perfectly
ordered morphology. However, limited spatial resolution and lack of porous materials have …